Insight on Bacterial Newborn Meningitis Using a Neurovascular-Unit-on-a-Chip
暂无分享,去创建一个
Ben M. Maoz | D. Biran | E. Ron | R. Rauti | Yael Leichtmann-Bardoogo | Keshet Tadmor | Sharon Navok
[1] Y. Bahn,et al. Pathogens infecting the central nervous system , 2022, PLoS pathogens.
[2] Ben M. Maoz. Brain-on-a-Chip: Characterizing the next generation of advanced in vitro platforms for modeling the central nervous system , 2021, APL bioengineering.
[3] Ben M. Maoz,et al. Biology and Models of the Blood-Brain Barrier. , 2021, Annual review of biomedical engineering.
[4] F. Iovino,et al. Neuronal Damage and Neuroinflammation, a Bridge Between Bacterial Meningitis and Neurodegenerative Diseases , 2021, Frontiers in Cellular Neuroscience.
[5] Ben M. Maoz,et al. Transforming a well into a chip: A modular 3D-printed microfluidic chip , 2021, APL bioengineering.
[6] Ben M. Maoz,et al. Effect of SARS-CoV-2 proteins on vascular permeability , 2021, bioRxiv.
[7] F. Gomes,et al. Ethanol Gestational Exposure Impairs Vascular Development and Endothelial Potential to Control BBB-Associated Astrocyte Function in the Developing Cerebral Cortex , 2021, Molecular Neurobiology.
[8] Rossana Rauti,et al. Recent progress in translational engineered in vitro models of the central nervous system , 2020, Brain : a journal of neurology.
[9] Kayoko Yamada,et al. Overcoming the Challenges of Megabase-Sized Plasmid Construction in Escherichia coli. , 2020, ACS synthetic biology.
[10] M. Prato,et al. Tuning Neuronal Circuit Formation in 3D Polymeric Scaffolds by Introducing Graphene at the Bio/Material Interface , 2020, Advanced biosystems.
[11] L. Ballerini,et al. Bilirubin disrupts calcium homeostasis in neonatal hippocampal neurons: a new pathway of neurotoxicity , 2020, Archives of Toxicology.
[12] Weijia Wen,et al. Organ-on-a-chip: recent breakthroughs and future prospects , 2020, BioMedical Engineering OnLine.
[13] D. Biran,et al. Escherichia coli O-antigen Capsule (Group 4) is Essential for Serum Resistance. , 2020, Research in microbiology.
[14] C. Schwerk,et al. Virulence Factors of Meningitis-Causing Bacteria: Enabling Brain Entry across the Blood–Brain Barrier , 2019, International journal of molecular sciences.
[15] R. Cohen,et al. Combination therapy with ciprofloxacin and third-generation cephalosporin versus third-generation cephalosporin monotherapy in Escherichia coli meningitis in infants: a multicentre propensity score-matched observational study. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[16] M. Prato,et al. Chemically Cross-Linked Carbon Nanotube Films Engineered to Control Neuronal Signaling. , 2019, ACS nano.
[17] D. Scaini,et al. Carbon Nanotubes, Directly Grown on Supporting Surfaces, Improve Neuronal Activity in Hippocampal Neuronal Networks , 2019, Advanced biosystems.
[18] V. Masignani,et al. The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology , 2019, Front. Immunol..
[19] R. Rappuoli,et al. Meningococcal B vaccine (4CMenB): the journey from research to real world experience , 2018, Expert review of vaccines.
[20] M. Mohammadi,et al. Fullerenol Nanoparticles Decrease Blood-Brain Barrier Interruption and Brain Edema during Cerebral Ischemia-Reperfusion Injury Probably by Reduction of Interleukin-6 and Matrix Metalloproteinase-9 Transcription. , 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[21] Huanchun Chen,et al. New insights into meningitic Escherichia coli infection of brain microvascular endothelial cells from quantitative proteomics analysis , 2018, Journal of Neuroinflammation.
[22] Huanchun Chen,et al. New insights into meningitic Escherichia coli infection of brain microvascular endothelial cells from quantitative proteomics analysis , 2018, Journal of Neuroinflammation.
[23] Qihan Li,et al. miR-1303 regulates BBB permeability and promotes CNS lesions following CA16 infections by directly targeting MMP9 , 2018, Emerging Microbes & Infections.
[24] Bo Li,et al. Caspr1 is a host receptor for meningitis-causing Escherichia coli , 2018, Nature Communications.
[25] D. Conway,et al. Characterization of cell-cell junction changes associated with the formation of a strong endothelial barrier , 2018, Tissue barriers.
[26] J. O’Donnell,et al. Targeting von Willebrand Factor-Mediated Inflammation. , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[27] P. Lenting,et al. von Willebrand factor and inflammation , 2017, Journal of thrombosis and haemostasis : JTH.
[28] G. Limongelli,et al. The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy , 2017, Mediators of inflammation.
[29] Sean P. Palecek,et al. An isogenic blood–brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells , 2017, Journal of neurochemistry.
[30] B. Stoll,et al. Emergence of Antibiotic Resistance-Associated Clones Among Escherichia coli Recovered From Newborns With Early-Onset Sepsis and Meningitis in the United States, 2008-2009. , 2016, Journal of the Pediatric Infectious Diseases Society.
[31] Huanchun Chen,et al. Induction of VEGFA and Snail-1 by meningitic Escherichia coli mediates disruption of the blood-brain barrier , 2016, Oncotarget.
[32] L. Boyer. Escherichia coli K1 meningitis: Analysis of the effects of CNF1 toxin in newborn mice questions its virulence function. , 2016, Virulence.
[33] K. Kim. Human Meningitis-Associated Escherichia coli , 2016, EcoSal Plus.
[34] Mandy B. Esch,et al. TEER Measurement Techniques for In Vitro Barrier Model Systems , 2015, Journal of laboratory automation.
[35] K. Danker,et al. Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood–brain barrier model , 2014, Journal of Neuroscience Methods.
[36] G. Hatch,et al. The Blood Brain Barrier — Regulation of Fatty Acid and Drug Transport , 2014 .
[37] M. Vizcaychipi,et al. Neuroinflammation: The role and consequences , 2014, Neuroscience Research.
[38] Ron Milo,et al. Spanning high-dimensional expression space using ribosome-binding site combinatorics , 2013, Nucleic acids research.
[39] Kapil Pant,et al. SyM-BBB: a microfluidic Blood Brain Barrier model. , 2013, Lab on a chip.
[40] A. Berg,et al. BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function , 2013, Biomedical microdevices.
[41] Chulhee Choi,et al. Reliable permeability assay system in a microfluidic device mimicking cerebral vasculatures , 2012, Biomedical microdevices.
[42] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[43] Hanseup Kim,et al. Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). , 2012, Lab on a chip.
[44] Dora Brites,et al. Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches , 2010, Brain Research Reviews.
[45] N. Prasadarao,et al. BRAIN DAMAGE IN NEWBORN RAT MODEL OF MENINGITIS BY ENTEROBACTER SAKAZAKII: A ROLE FOR OUTER MEMBRANE PROTEIN A , 2009, Laboratory Investigation.
[46] K. Kim. Mechanisms of microbial traversal of the blood–brain barrier , 2008, Nature Reviews Microbiology.
[47] P. Fratamico,et al. Extraintestinal pathogenic Escherichia coli. , 2007, Foodborne pathogens and disease.
[48] Karl Herrup,et al. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? , 2007, Nature Reviews Neuroscience.
[49] Munhyang Lee,et al. Effects of dopamine infusion on cerebral blood flow, brain cell membrane function and energy metabolism in experimental Escherichia coli meningitis in the newborn piglet. , 2003, Journal of Korean medical science.
[50] K. Kim. Neurological diseases: Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury , 2003, Nature Reviews Neuroscience.
[51] H. Pfister,et al. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. , 2002, The Journal of infectious diseases.
[52] K. Kim. Escherichia coli Translocation at the Blood-Brain Barrier , 2001, Infection and Immunity.
[53] U. Gophna,et al. Curli Fibers Mediate Internalization ofEscherichia coli by Eukaryotic Cells , 2001, Infection and Immunity.
[54] A. Jong,et al. Further characterization of Escherichia coli brain microvascular endothelial cell invasion gene ibeA by deletion, complementation, and protein expression. , 2001, The Journal of infectious diseases.
[55] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[56] J. R. Johnson,et al. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. , 2000, The Journal of infectious diseases.
[57] Ying Wang,et al. The Gene Locus yijP Contributes to Escherichia coli K1 Invasion of Brain Microvascular Endothelial Cells , 1999, Infection and Immunity.
[58] Ying Wang,et al. Identification and Characterization of an Escherichia coli Invasion Gene Locus, ibeB, Required for Penetration of Brain Microvascular Endothelial Cells , 1999, Infection and Immunity.
[59] J. Hacker,et al. Virulence patterns from septicemic Escherichia coli O78 strains. , 1997, FEMS microbiology letters.
[60] R. van Furth,et al. Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy , 1996, Infection and immunity.
[61] N. Prasadarao,et al. Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10 , 1995, Infection and immunity.
[62] H. Pfister,et al. Mechanisms of brain injury in bacterial meningitis: workshop summary. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] A. Cross,et al. The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. , 1992, The Journal of clinical investigation.
[64] V. Lorenzo,et al. Aerobactin production as a virulence factor: A reevaluation , 1988, European Journal of Clinical Microbiology and Infectious Diseases.
[65] R. Wirth,et al. Transformation of bacteria with plasmid DNA by electroporation. , 1988, Analytical biochemistry.
[66] B. Paw,et al. Aerobactin biosynthesis and transport genes of plasmid ColV-K30 in Escherichia coli K-12 , 1986, Journal of bacteriology.
[67] S. Falkow,et al. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12 , 1985, Nature.
[68] R. Firth. Function , 1955, Yearbook of Anthropology.
[69] Ben M. Maoz,et al. Spatial Trans-Epithelial Electrical Resistance (S-TEER) Integrated in Organs-on-Chips , 2021, Lab on a Chip.
[70] K. Kim. Acute bacterial meningitis in infants and children. , 2010, The Lancet. Infectious diseases.
[71] I. Roberts,et al. Capsular polysaccharides in Escherichia coli. , 2008, Advances in applied microbiology.
[72] B. Moser,et al. Cytokines and chemokines in meningeal inflammation: biology and clinical implications. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[73] L. Drury,et al. Transformation of bacteria by electroporation. , 1996, Methods in molecular biology.
[74] H. Milch,et al. Escherichia coli Col V plasmids and their role in pathogenicity. , 1984, Acta microbiologica Hungarica.
[75] H. Milch,et al. Characterization of Escherichia coli serogroups causing meningitis, sepsis and enteritis. II. Classification of Escherichia coli O78 strains by phage sensitivity, colicin type and antibiotic resistance. , 1977, Acta microbiologica Academiae Scientiarum Hungaricae.